Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

10 Approvals To Look Out For In Q2

Apr 20 2023

• By Alexandra Shimmings

FDA approved background, 3D rendering, blue street sign — • Source: Shutterstock

Related Content

Sun Pharma Will Take Concert’s Alopecia Drug The Rest Of The Way

Jan 19 2023

Accelerated Approval Is US FDA Panel’s Preferred Path For Biogen/Ionis’s Tofersen In ALS

Mar 23 2023

CBER Director Marks’ Intervention On Sarepta Gene Therapy Filing Decision Appears To Backfire

Apr 15 2023

FDA Advisors Give Entasis Antibiotic Unanimous Thumbs Up, But Call For Strong Postmarket Surveillance

Apr 18 2023

Both Pfizer And GSK RSV Vaccines Set For Approval – But Could Next Readouts Give One The Edge?

Mar 06 2023

J&J Quits RSV Development With Two Rivals Already Poised For US Approval

Mar 29 2023

Byondis Seeks Partner For Lead ADC To Enter Crowded Breast Cancer Market

Jun 09 2021

Biogen Prepares More Doubtful Phase III Results For FDA Scrutiny, This Time In ALS

Sep 23 2022

Lilly's Olumiant Is First Drug FDA Approved For Alopecia Areata

Jun 13 2022

Another New Home For Momelotinib As GSK Buys Sierra

Apr 13 2022

Protalix Plans US Resubmission For ERT For Fabry After Positive Phase III Trial Results

Apr 04 2022

Sun Eyes Big Stage For Concert’s Alopecia Asset

Feb 10 2023

Bavarian Nordic Comes Up On The Rails In RSV Race

Apr 12 2023

Related Companies

Ionis Pharmaceuticals, Inc.

AstraZeneca PLC

Sanofi

Pfizer Inc.

GSK plc

Agenus Inc.

Johnson & Johnson

Bavarian Nordic A/S

Chiesi Farmaceutici S.p.A.

Protalix BioTherapeutics, Inc.

Byondis B.V.

Seagen Inc.

MacroGenics, Inc.

Sarepta Therapeutics, Inc.

Eli Lilly and Company

Concert Pharmaceuticals, Inc.

Sun Pharmaceutical Industries Ltd.

Sierra Oncology, Inc.

Intercept Pharmaceuticals, Inc.

Additional Topics

Approvals Companies Research & Development Regulation Cancer Dermatology Infectious Diseases Liver & Hepatic Metabolic Disorders BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.